{
    "id": 6125,
    "fullName": "MDM4 amp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "MDM4 amp indicates an increased number of copies of the MDM4 gene. However, the mechanism causing the increase is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 4194,
        "geneSymbol": "MDM4",
        "terms": [
            "MDM4",
            "HDMX",
            "MDMX",
            "MRP1"
        ]
    },
    "variant": "amp",
    "createDate": "05/15/2015",
    "updateDate": "11/29/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9313,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, human glioblastoma multiforme cell lines with gain or amplification of MDM4 and wild-type TP53 demonstrated sensitivity to RG7112 in culture, resulting in decreased cell viability (PMID: 26482041).",
            "molecularProfile": {
                "id": 26818,
                "profileName": "MDM4 amp TP53 wild-type"
            },
            "therapy": {
                "id": 2076,
                "therapyName": "RG7112",
                "synonyms": null
            },
            "indication": {
                "id": 3068,
                "name": "glioblastoma multiforme",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 7072,
                    "pubMedId": 26482041,
                    "title": "Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26482041"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 5969,
            "profileName": "MDM4 amp",
            "profileTreatmentApproaches": [
                {
                    "id": 4556,
                    "name": "MDM4 inhibitor",
                    "profileName": "MDM4 amp"
                }
            ]
        },
        {
            "id": 26818,
            "profileName": "MDM4 amp TP53 wild-type",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}